A phase I study of PRT3789, a potent and selective degrader of SMARCA2 in patients with advanced or metastatic solid tumors and a SMARCA4 mutation Meeting Abstract
| Authors: | Dagogo-Jack, I.; Dowlati, A.; Guo, R.; Awad, M. M.; Swalduz, A.; Calvo, E.; Garcia, V. M.; Adjei, A. A.; Lorusso, P.; Punekar, S.; Leal, T. A.; Yap, T. A.; Italiano, A.; Novotny, W.; Tankersley, C.; Rowe, S.; Paris, G.; Sun, W.; Spira, A. I.; Besse, B. |
| Abstract Title: | A phase I study of PRT3789, a potent and selective degrader of SMARCA2 in patients with advanced or metastatic solid tumors and a SMARCA4 mutation |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S493 |
| End Page: | S494 |
| Language: | English |
| ACCESSION: | WOS:001087480201055 |
| DOI: | 10.1016/j.annonc.2023.09.1899 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 713TiP -- Source: Wos |
